An Ebola vaccine tested by a London university has made its way into a 27,000-person clinical trial in West Africa. The number of volunteers involved in the trial just tops the number of people that have been infected with Ebola since the outbreak began — a harrowing 25,178.
St George’s, University of London is part of a global effort to speedily bring Ebola vaccine rVSV-ZEBOV to the regions most impacted by the deadly virus, and this week a paper published in the New England Journal of Medicine has shown just how much promise that vaccine has.
By: Liat Clark,